<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

2 min read

European Biomanufacturing Summit 2023

European Biomanufacturing Summit 2023

Date: May 31 - June 1, 2023

Location: Titanic Chaussee Berlin, Germany - Directions

Event Website: https://biomaneurope.com/

MEET OUR TEAM AND LEARN ABOUT AGC BIOLOGICS

Swing by our booth at the event and learn about our services or you can send us an email if you'd like to set up a meeting to discuss how our global network and capabilities can bring your product to the next step.

Click the link above to get all the details. 

 

REQUEST A MEETING

You can also reach out directly to our experts attending the show

Satish Bachu
Principal Scientist, Downstream Late Stage Specialist

Email  me

Christoph Winterhalter
Sr. Vice President, Business Development
Email  me
Samuel Neill
Director, Business Development
Email me
Samuele Corbetta
Sr. Scientist, Downstream Vector Development Specialist
Email me

LEARN ABOUT OUR protein biologics Services

Mammalian bioprocessing systems

We have several decades of experience with mammalian-based bioprocessing production, and can support your project from cell line development through full-scale commercialization. We offer a variety of flexible single-use manufacturing scales with options for multiple configurations at our sites in the U.S., Europe, and Japan, and have large-scale commercial capabilities using  stainless steel reactors at our site in Boulder, CO, USA.

Learn more about our mammalian services

Microbial bioprocessing systems

We have produced 100+ products using microbial expressed proteins and multiple modes of expression - including secretion (yeast), periplasmic secretion, soluble intracellular expression, and inclusion bodies, also from initial development through full-scale.  commercialization. Our expertise includes experience with E. coli, Pichia, Pseudomonas Fluorescens, Bacillus microbial expression systems, and more.

We use standard industry systems, including batch and fed-batch methods, to produce microbial drug products, and offer cell banking services that meet the standards of regulatory agencies worldwide, and flexible manufacturing scales to support any stage of your product lifecycle. 

Learn more about our microbial services

Process development capabilities 

At AGC Biologics we have developed over 200 mammalian, bacteria, and yeast-based processes. Whether you need assistance developing a de novo process, improving existing processes, or preparing to manufacture your product, you will benefit from our expertise.

Learn more about our process development services

cGMP manufacturing capabilities 

Our seven state-of-the-art facilities across the globe offer innovative design, expanding capacity, technological ingenuity, and teams dedicated to strict biopharmaceutical regulations required for cGMP operations.

Learn more about our cGMP services

Quality systems and regulatory inspection management support

At each of our manufacturing facilities, highly trained Quality Units maintain strict quality systems to support our cGMP manufacturing efforts and to ensure compliance with all regulatory requirements. 

Learn more about our quality systems and inspection management

Fill out the form below to request a meeting during the event

 

Bio Korea 2024, May 8-10

Bio Korea 2024, May 8-10

CPHI North America, May 7-9

CPHI North America, May 7-9

ASGCT Annual Meeting, May 7-11

ASGCT Annual Meeting, May 7-11